The conformational epitope of type III group B Streptococcus capsular polysaccharide

Advances in Experimental Medicine and Biology

Volumn 491, Issue , 2001, Pages 473-484

  Zou, W ^a   Jennings, H J ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BACTERIAL POLYSACCHARIDE; EPITOPE; OLIGOSACCHARIDE;

ANTIGENICITY; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; CROSS REACTION; GLYCOSYLATION; IMMUNE SYSTEM; POLYMERIZATION; PRIORITY JOURNAL; STREPTOCOCCUS;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS; STREPTOCOCCUS SP. 'GROUP B';

EID: 0034956808     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-1267-7_31     Document Type: Conference Paper

References (27)

1. Structure, conformation, and immunology of sialic acid-containing polysaccharides of human pathogenic bacteria
2. Polysaccharides and conjugated polysaccharides as human vaccines
3. Capsular polysaccharides as vaccine candidates
4. Structural determination of the capsular polysaccharide antigen of type II group B Streptococcus
5. Structure of native polysaccharide antigens of type Ia and type Ib group B Streptococcus
6. Structure of the capsular polysaccharide antigen of Type IV Group B Streptococcus
7. Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharide
8. Structure of the type VI group B Streptococcus capsular polysaccharide determined by high resolution NMR spectroscopy
9. Structural elucidation of the novel type VII group B Streptococcus capsular polysaccharide by high resolution NMR spectroscopy
10. Structure and immunochemical characterization of the type VIII group B Streptococcus capsular polysaccharide
11. Conformational aspects critical to the immuno-specificity of the type III Group B streptococcal polysaccharide
12. An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B Streptococcus
13. Group B Streptococcus type III glycoconjugate vaccines
14. Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates
15. Oligosaccharide fragments of the type III group B Streptococcal polysaccharide derived from S. pneumoniae type 14 capsular polysaccharide by a chemoenzymatic method
16. Mimics of the structural elements of type III group B Streptococcus capsular polysaccharide. Part I. Synthesis of a carboxylate-containing pentasaccharide
17. Mimics of the structural elements of type III group B streptococcus capsular polysaccharide. Part III: Two repeating units (octasaccharide) with (s)-1-carboxyethyl groups replacing sialic acids
18. 13C-labeled and N-propionyl subsituted sialic acid analogues
19. Conformational epitope of the type III group B Streptococcus capsular polysaccharide
20. A model of high affinity antibody binding to type III group B Streptococcus capsular polysaccharide
21. Determinant specificities of the groups B and C polysaccharides of Neisseria meningitidis
22. Helical epitope of the group B meningococcal α(2-8)-linked sialic acid polysaccharide
23. Streptococcus pneumoniae type 14 polysaccharide-conjugate vaccines: Length stablization of opsonophagocytic conformational polysaccharide epitopes
24. Antibody recognition of the type 14 pneumococcal capsule
25. NMR and molecular dynamics studies of the conformational epitope of the type III group B Streptococcus capsular polysaccharide and derivatives
26. Evidence for the extended helical nature of polysaccharide epitopes. The 2.8 A resolution structure and thermodynamics of ligand binding of an antigen binding fragment specific of α(2-8)- polysialic acid
27. Enzymes in organic synthesis: Application to the problems of carbohydrate recognition (Part 2)